Miami-based Neocis, a startup pioneering in robot-assisted dental implant surgery, has secured $20 million in funding from Mirae Asset Capital and NVentures to advance further Yomi, the first and only FDA-cleared robotic system transforming dental implant procedures.
“We’re tremendously grateful to have the backing of our newest investors, including NVentures and Mirae Asset Financial Group, as well as our existing partners. This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry,” said Alon Mozes, Neocis’ co-founder and CEO.
Yomi, the first and only robotic surgical system FDA-cleared for dental implant procedures, has garnered widespread acclaim since its inception in 2016. With 16 FDA 510(k) clearances, the Yomi platform facilitates precise and efficient treatment through streamlined digital planning and haptic guidance.
“The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” said Alon Mozes. Clinicians have successfully placed over 40,000 implants with Yomi, an impressive figure highlighting the system’s growing acceptance and adoption.
Revolutionizing Dental Implant Surgery
Neocis, named one of South Florida’s fastest-growing companies in 2023, has strategically employed the additional funds to fuel various business initiatives. These encompass product development, sales enablement, and clinical education. All align with the company’s commitment to advancing patient care and improving overall quality of life.
The expansion into a larger headquarters in Miami’s Wynwood neighborhood last summer, featuring a state-of-the-art manufacturing facility, further underscores Neocis’s commitment to sustained growth.
Investor Confidence in Dental Robotics
Investors Mirae Asset Capital and NVentures express confidence in Neocis’s trajectory. “Robotics and AI are changing the face of dentistry, enabling innovations that increase doctor efficiency and help them improve the quality of life for their patients,” said Mohamed Siddeek, corporate vice president and head of NVentures.
The latest funding positions Neocis for continued success, driving meaningful innovation in robotic dental surgery.
The Yomi robotic system, developed by Neocis, has come a long way since its inception in 2008. The system utilizes haptic feedback, intuitive visualization, and audio cues to enhance clinician accuracy during implant placement.
This innovation in dental robotics has garnered over 10,000 placements by the beginning of 2022, which has now surged to an impressive 40,000.
Optimizing for the Future
Neocis’s latest funding injection marks a critical moment for Yomi, solidifying its position as the premier robotic surgical system for dental implant procedures. The investment reflects growing confidence in the transformative power of dental robotics, underscoring Neocis’s commitment to pushing the boundaries of innovation in the field.
“Neocis is bringing needed innovation to robotic dental surgery, and we couldn’t be more excited to support them in that mission,” said Mirae Asset Capital’s Investment Manager, Soojung Kim. “We look forward to working alongside the Neocis team to help them excel in a rapidly growing market and get Yomi in the hands of more providers.”
Follow USTechTimes on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in USA.
We Recommend:
- Imagoworks’ AI-based web dental CAD 3Dme Crown gets global attention
- Noah Medical Secures $150 million to build lung scanning robots
- Exo Bags $220 Million as Hand-Held Ultrasound Device’s Race Intensifies
- AI-enabled Heart health monitoring startup Cleerly raises $192 million
- Renibus Therapeutics secures $47M funding to advance promising drug for postoperative complications following cardiothoracic surgery
